Navigation Links
European Commission Designates MST-188 As An Orphan Medicinal Product
Date:3/25/2013

ST-188 in acute limb ischemia, a complication of peripheral arterial disease, in late 2013 or early 2014.  More information can be found on the Company's web site at www.masttherapeutics.com.

Forward Looking Statements

Mast Therapeutics cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that are based on the Company's current expectations and assumptions. Such forward-looking statements include, but are not limited to, statements regarding prospects for success of MST-188 development programs in and outside of the U.S., the Company's focus on and the potential for strategic alliances involving MST-188, the positive effects that the EMA's orphan designation may have on MST-188's regulatory, commercial and partnering prospects, including the potential for 10-year marketing exclusivity and for increasing partnering interest in the EU, and the potential benefits of partnering MST-188, including enabling its development in multiple countries, enhancing the overall commercial opportunity for MST-188 and funding its development within the U.S. Among the factors that could cause or contribute to material differences between the Company's actual results and expectations indicated by the forward-looking statements are risks and uncertainties that include, but are not limited to: the risk that, upon re-evaluation at the time of application to the EMA for marketing authorization, the COMP or the EC may determine that MST-188 for the treatment of sickle cell disease no longer meets the criteria for orphan designation, meaning that MST-188 would not benefit from the 10-year marketing exclusivity for authorized orphan medicines; the potential that partnering transactions involving MST-188 may not advance its development in other jurisdictions, enhance the overall commercial opportunity of the product candidate or help fund its de
'/>"/>

SOURCE Mast Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
2. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
3. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
4. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
5. Mylan Launches Generic Lipitor® in Five European Countries
6. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
7. Bristol-Myers Squibb to Present New Data on ORENCIA(R)? (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
8. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
9. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
10. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
11. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... -- ACI Clinical ( www.aciclinical.com ) announces a new, ... Using this solution, trial sponsors can save ... and receive the same expertise that has made ... Leveraging a decade of DMC experience (initial ... programming and meeting facilitation), ACI analyzed DMC member ...
(Date:8/21/2014)... PARK, N.J. , Aug. 21, 2014 /PRNewswire/ ... pharmacy group purchasing organization (GPO), is pleased to ... to collaborate on a host of innovative specialty ... help Aurora deliver enhanced therapy management services to ... Management (OTM) system. Aurora will use ...
(Date:8/21/2014)... 2014  The board of directors of VirtualScopics, Inc. ... clinical trial imaging solutions, today announced that James ... effective immediately.  Mr. Groff has held the role of ... VirtualScopics in January 2006 as an accounting manager and ... "When the board of VirtualScopics asked Jim to assume ...
Breaking Medicine Technology:ACI Clinical: Innovation and Savings in Data Safety Monitoring Committees 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 2VirtualScopics, Inc. Names James Groff Chief Financial Officer 3VirtualScopics, Inc. Names James Groff Chief Financial Officer 4
(Date:8/21/2014)... Aug. 21, 2014 (HealthDay News) -- Black mothers are ... and here,s one possible reason why: Hospitals in neighborhoods ... than those in areas with more white residents, a ... breast-feeding are much less common in medical centers where ... the U.S. Centers for Disease Control and Prevention reported ...
(Date:8/21/2014)... 21, 2014 The W. Montague ... and a national voice in the elimination of ... disparities during the 112th National Medical Association’s (NMA) ... included: , John Ruffin, Ph.D, former Director of ... Disparities, whose life-long career and innovations have had ...
(Date:8/21/2014)... communities do not routinely screen women for intimate ... and public health researchers. Rural women who are ... they seek help., "Rural health care providers are ... McCall-Hosenfeld, a primary care physician and assistant professor ... College of Medicine. "However, in rural settings, it ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 The ... Market by Pollutant Control System (FGD, DeNOx, Particulate ... Iron & Steel, Chemical & Others) - Global ... the global industrial flue gas treatment systems & ... global market size in terms of value. The ...
(Date:8/21/2014)... August 21, 2014 The Swedish-American ... year's conference will focus on the Future of ... research, innovation and commercialization. , With the mission ... combines the worlds' of business and science. "Over ... recognized Summit, gathering a diverse community with representatives ...
Breaking Medicine News(10 mins):Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2Health News:W. Montague Cobb/NMA Health Institute Honors Three Outstanding Leaders in Health Disparities 2Health News:Primary care physicians can be critical resource for abused women in rural areas 2Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 2Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 3Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 4Health News:The Tenth Swedish-American Life Science Summit, takingplace in Stockholm, Sweden, August 20-22nd, will focus on The Future of Medicine 2
... biomarker that enables close to 98 percent accuracy in predicting ... study is published in the March 1 issue of Clinical ... Research. , When cancer spreads beyond a solid tumor, ... cannot be identified by conventional imaging methods such as CT ...
... release is available in Spanish . , ... of the University of Navarra have discovered the molecular ... for primary biliary cirrhosis, which combines two substances in ... from either substance separately. The discovery involved the role ...
... rising consumer demand for organic milk, BROOMFIELD, Colo., ... company, today announced that the brand,expanded its farmer partner ... nearly 450 family farmer partners in 22 states across ... to becoming certified,organic., "Family farms have been at ...
... a Sense of Purpose, WASHINGTON, Feb. 27 ... during Operation Iraqi,Freedom and Operation Enduring Freedom (OIF/OEF), will ... Winter Sports Clinic in,Snowmass Village, March 30 - April ... physical, social, and emotional,well-being of the veterans who participate ...
... Inc. ("Versus" or the "Company") announced revenues of,$1,426,000 ... 2008, a 26%,increase over revenues of $1,133,000 for ... revenues can vary significantly depending upon the,timing of ... in any one quarter are not necessarily indicative ...
... Gains Momentum, Physicians Trumpet, the Value of ePrescribing in Significantly ... ... Care, DETROIT, Feb. 27 Efforts to expand the use ... ePrescribing receives high marks from constituents,whose opinion about the technology may ...
Cached Medicine News:Health News:New blood marker may predict prostate cancer spread 2Health News:New blood marker may predict prostate cancer spread 3Health News:Cause of effectiveness discovered for a cirrhosis treatment useful in 40 percent of patients 2Health News:Horizon Organic(R) Family Farmer Network Grows by Nearly 35 Percent 2Health News:World's Largest Disabled Ski Clinic at Snowmass, Colo. 2Health News:Versus Technology Announces First Quarter Results 2Health News:Versus Technology Announces First Quarter Results 3Health News:Versus Technology Announces First Quarter Results 4Health News:Versus Technology Announces First Quarter Results 5Health News:Versus Technology Announces First Quarter Results 6Health News:Prescription for Change: New Survey Shows ePrescribing Connecting with its Biggest Skeptics ... Physicians 2Health News:Prescription for Change: New Survey Shows ePrescribing Connecting with its Biggest Skeptics ... Physicians 3Health News:Prescription for Change: New Survey Shows ePrescribing Connecting with its Biggest Skeptics ... Physicians 4Health News:Prescription for Change: New Survey Shows ePrescribing Connecting with its Biggest Skeptics ... Physicians 5Health News:Prescription for Change: New Survey Shows ePrescribing Connecting with its Biggest Skeptics ... Physicians 6Health News:Prescription for Change: New Survey Shows ePrescribing Connecting with its Biggest Skeptics ... Physicians 7
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: